John Theurer Cancer Center at HackensackUMC

Hackensack, New Jersey 07601

7 studies enrolling now · 26 studies all time

What they study most

Acute GVHD, Acute Myeloid Leukemia, Acute Myeloid Leukemia (AML), Acute-graft-versus-host Disease, Advanced Endometrial Carcinoma, Advanced Gastric Carcinoma, Advanced Lung Cancer, Advanced Malignancies, Advanced Ovarian Carcinoma, Advanced Solid Tumor, B-cell Non-Hodgkin Lymphoma (B-NHL), CCNE1 Amplification

Studies at this site

• Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301) — Recruiting now
• A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer — Recruiting now
• A Study of LY4175408 in Participants With Advanced Cancer — Recruiting now
• A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors — Recruiting now
• A Study of I-DXd in Combination With Atezolizumab With or Without Carboplatin as First-Line Induction or Maintenance in Subjects With Extensive Stage-Small Cell Lung Cancer (IDeate-Lung03) — Recruiting now
• Pembrolizumab and Lenvatinib in Advanced Cervical Cancer — Recruiting now
• A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma — Recruiting now
• A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies — Running, not enrolling
• A Phase 2b Clinical Study With a Combination Immunotherapy in Newly Diagnosed Patients With Glioblastoma — Running, not enrolling
• Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML — Completed
• Phase II Protocol for CLL With Fludarabine and Cyclophosphamide With Rituximab (FCR) Plus Lenalidomide — Completed
• Ph2, Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant — Completed
• Study of 225Ac-SS0110 in Subjects With ES-SCLC or MCC (SANTANA-225 ) — Stopped early
• Claudin 18.2-Targeted Chimeric Antigen Receptor T-cells in Subjects With Unresectable, Locally Advanced, or Metastatic Gastric, Gastroesophageal Junction (GEJ), Esophageal, or Pancreatic Adenocarcinoma — Running, not enrolling
• Efficacy of MT-401 in Patients With AML Following Stem Cell Transplant — Stopped early
• GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease — Completed
• A Single-arm, Multicenter Study to Assess the Efficacy, Safety, and Tolerability of P1101 in Adults With ET — Running, not enrolling
• A Study of Itolizumab in Combination With Corticosteroids for the First-Line Treatment of Acute Graft Versus Host Disease (EQUATOR) — Stopped early
• Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV+ Lymphoid Malignancies — Completed
• Study of the Safety, Tolerability and Efficacy of KPT-8602 in Participants With Relapsed/Refractory Cancer Indications — Completed
• SG2501 Safety Study in Subjects with Relapsed or Refractory Hematological Malignancies and Lymphoma. — Stopped early
• Study of bb21217 in Multiple Myeloma — Completed
• A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies — Completed
• Selinexor Combination Ph 1 Study — Withdrawn before enrolling
• A Study of Extended Carfilzomib Therapy for Patients Previously Enrolled in Carfilzomib Treatment Protocols — Completed
• Phase 1b/2 Study of Carfilzomib, Carboplatin, and Etoposide in Patients With Previously Untreated Extensive Stage Small-cell Lung Cancer — Completed